Lyme disease is contagious and caused by a genus of bacteria. It is passed on to human beings from infected ticks. The symptoms of this illness include depression, fever, tiredness and rashes on the skin. The lyme disease diagnostic market is fragmented into diagnostic tests, consumers, geographical regions and evolving technologies of diagnostics.
Some of the tests for diagnosing lyme disease include Western Blot, Elisa and Polymerase Chain Reaction (PCR). North America occupies the biggest share in the lyme disease diagnostic market. This is due to the prevalence of the most widespread tick disease in the United States of America. Increasing cases of lyme disease and the need to diagnose it on time drive the lyme disease diagnostic market.